serena williams glp-1 medication weight loss drug: Tennis star says injections through Ro helped her lose 31 pounds Serena Williams reveals 31-pound weight

In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity

[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Munro I.A., Garg M.L

But the downstream cascade, the adrenaline release, the cortisol spike, the physical manifestations, are essentially identical

Safety history: pancreatitis, gallbladder disease, kidney disease, or thyroid cancer risk

This risk has only been observed in animal studies

Notably, GLP-1(936) increased dissociation of the inhibitory GTP-binding protein G oA (Fig